Dysregulated neutrophil activation contributes to the pathogenesis of autoimmune diseases
including rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Neutrophil …

The prognosis in systemic lupus erythematosus (SLE) has improved due to better treatment
and care, but cardiovascular disease (CVD) still remains an important clinical problem, since …

Increased risk of premature cardiovascular disease (CVD) is well recognized in systemic
lupus erythematosus (SLE). Aberrant type I-Interferon (IFN)-neutrophil interactions contribute …

Recent discoveries have further strengthened the critical role of SLE-related immune
dysregulation and metabolic disturbances in promoting accelerated CVD. Understanding …

BACKGROUND. Systemic lupus erythematosus (SLE) is associated with enhanced risk of
atherosclerotic cardiovascular disease not explained by Framingham risk score (FRS) …

Systemic lupus erythematosus (SLE) is a heterogeneous disease characterized by the
production of abnormal autoantibodies and immune complexes that can affect the organ and …

Systemic lupus erythematosus (SLE) often features extensive cardiovascular (CV)
comorbidity and patients with SLE are at significantly increased risk of CV event occurrence …

The observations that traditional cardiovascular disease (CVD) risk factors fail to fully
account for the excessive cardiovascular mortality in patients with systemic lupus …

Systemic lupus erythematosus (SLE) is associated with a significant risk of cardiovascular
disease (CVD), which substantially increases disease mortality and morbidity. The overall …

Sepsis is a major health issue with mortality exceeding 30% and few treatment options. We
found that high-density lipoprotein cholesterol (HDL-C) abundance was reduced by 45% in …